keyboard_arrow_up

Metabolomics Market – By Indication (Oncology, Cardiology) worth $2,100 Million by 2019

The “Metabolomics Market by Technique (Gas Chromatography, High Performance Liquid Chromatography, Nuclear Magnetic Resonance Spectroscopy, Mass Spectrometry, by Application (Biomarker & Drug Discovery, Nutrigenomics), by Indication (Oncology, Cardiology) - Global Forecast to 2019” analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia-Pacific, and the Rest of the World.

The global metabolomics market was valued at $565 million in 2014 and is expected to grow at a high CAGR during the forecast period of 2014 to 2019. This market is mainly driven by the increase in government and private funding for metabolomics research and the growing demand for personalized medicine. Moreover, growth in the pharmaceutical and biotechnology industries is also expected to contribute to the growth of the market. However, the market growth will be restrained to an extent due to several factors such as low adoption rate of metabolomics, data complexity, and lack of skilled professionals.

 Speak to Analyst: http://www.marketsandmarkets.com/speaktoanalyst.asp?id=900

 The global market is segmented based on techniques, applications, indications, and geography. Based on techniques, the market is classified into Gas Chromatography, High Performance Liquid Chromatography (HPLC), Ultra Performance Liquid Chromatography (UPLC), Nuclear Magnetic Resonance Spectroscopy (NMR), Mass Spectrometry (MS), and Surface-based Mass Analysis. The metabolomics application market covers biomarker discovery, drug discovery/drug assessment, toxicology testing, nutrigenomics, and others. Furthermore, based on indications, the metabolomics market is classified into oncology, neurology, cardiology, and others. The market is further divided into four major geographies, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW). These regions are further analyzed at the country level. The research report discusses about the key market drivers, restraints, and opportunities of the global market and its submarkets.

Request for Customization: http://www.marketsandmarkets.com/requestCustomization.asp?id=900

In 2013, the high performance liquid chromatography (HPLC) segment commanded the largest share of the global metabolomics market. The large share of the HPLC segment can be attributed to its wide application in biomarker discovery. The HPLC segment will continue to dominate this market by 2019, growing at a moderate CAGR during the forecast period. Furthermore, the rising demand for personalized medicine and increased necessity for toxicology testing are also expected to drive the growth of the market.

North America accounts for the largest share to the global market, followed by Europe, Asia-Pacific, and RoW. The European region is expected to grow at the highest CAGR during the forecast period, largely driven by the increasing research funding form governments and private investors and growing demand for personalized medicine.

The major players in the market include Thermo Fisher Scientific, Inc. (U.S.), Danaher Corporation (U.S.), Waters Corporation (U.S.), Agilent Technologies (U.S.), Metabolon, Inc. (U.S.), Shimadzu Corporation (Japan), Bruker Corporation (U.S.), and Biocrates Life Sciences AG. (Austria).

Browse related reports:

Proteomics Market by Technology (Protein Microarray, Mass Spectrometry, NMR Spectroscopy, Chromatography, Electrophoresis, Surface Plasmon Resonance, X-ray Crystallography) - Instruments, Reagents & Services - Global Forecast to 2018
http://www.marketsandmarkets.com/Market-Reports/proteomics-market-731.html

Gene Expression Analysis Market by Technology (DNA Microarray, Real-Time PCR, Next Generation Sequencing), Consumables (DNA Chips, Reagents), Services (Gene Profiling, Bioinformatics, Data Analysis Software) & Applications] - Global Forecast to 2018
http://www.marketsandmarkets.com/Market-Reports/gene-expression-analysis-market-156613968.html

 About MarketsandMarkets

MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, healthcare IT, medical devices, pharmaceuticals, semiconductor and electronics, aerospace & defense.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit MarketsandMarkets Blog @  http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets